Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Blueprint Medicines Raises FY21 Sales Guidance To $170M-$180M vs $148.4M Estimate


Benzinga | Oct 28, 2021 07:37AM EDT

Blueprint Medicines Raises FY21 Sales Guidance To $170M-$180M vs $148.4M Estimate






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC